Induction of cytochrome P450IA genes (CYP1A) by omeprazole in the human alimentary tract.

[1]  R. Bergstrand,et al.  Omeprazole treatment does not affect the metabolism of caffeine. , 1991, Gastroenterology.

[2]  M. J. Coon,et al.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. , 1991, DNA and cell biology.

[3]  S. Wrighton,et al.  Nonuniform distribution of cytochrome P450IA2 in liver. , 1991, Gastroenterology.

[4]  G. Olson,et al.  Induction of nuclear anomalies in the gastrointestinal tract by polycyclic aromatic hydrocarbons. , 1991, Cancer letters.

[5]  L Roberts,et al.  Dioxin risks revisited. , 1991, Science.

[6]  P. Traber.  Regulation of sucrase-isomaltase gene expression along the crypt-villus axis of rat small intestine. , 1990, Biochemical and biophysical research communications.

[7]  B. Ames,et al.  Dietary pesticides (99.99% all natural). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Farrell,et al.  Human cytochrome P450 isoforms , 1990 .

[9]  P. Maurel,et al.  Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. , 1990, Gastroenterology.

[10]  M. McDonnell,et al.  P450IIB gene expression in rat small intestine: cloning of intestinal P450IIB1 mRNA using the polymerase chain reaction and transcriptional regulation of induction. , 1990, Molecular pharmacology.

[11]  P. Beaune,et al.  Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. , 1990, The Journal of pharmacology and experimental therapeutics.

[12]  K. J. Cole,et al.  The inducibility and catalytic activity of cytochromes P450c (P450IA1) and P450d (P450IA2) in rat tissues. , 1990, Biochemical pharmacology.

[13]  P. Watkins,et al.  Distribution of cytochromes P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase in an entire human liver. , 1990, Biochemical pharmacology.

[14]  D. Nebert,et al.  Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. , 1989, Molecular endocrinology.

[15]  W. Peters,et al.  Cytochromes P-450 in the intestinal mucosa of man. , 1989, Biochemical pharmacology.

[16]  J. Concordet,et al.  Illegitimate transcription: transcription of any gene in any cell type. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Mäki,et al.  Mucosal biotransformation rates in the small intestine of children. , 1988, Gut.

[18]  P. Traber,et al.  Expression of cytochrome P450b and P450e genes in small intestinal mucosa of rats following treatment with phenobarbital, polyhalogenated biphenyls, and organochlorine pesticides. , 1988, The Journal of biological chemistry.

[19]  J. Fagan,et al.  Transcriptional and post-transcriptional regulation of the genes encoding cytochromes P-450c and P-450d in vivo and in primary hepatocyte cultures. , 1988, The Journal of biological chemistry.

[20]  F. Guengerich.  Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. , 1988, Cancer research.

[21]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[22]  D. Nebert,et al.  Human P3(450): cDNA and complete amino acid sequence. , 1986, Nucleic acids research.

[23]  D. Nebert,et al.  Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues , 1986, Molecular and cellular biology.

[24]  R. Mayer,et al.  Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. , 1985, Biochemical pharmacology.

[25]  B. Moats-Staats,et al.  Nucleotide sequence analysis of a cDNA encoding human ubiquitin reveals that ubiquitin is synthesized as a precursor. , 1985, The Journal of biological chemistry.

[26]  D. Nebert,et al.  Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. , 1985, Nucleic acids research.

[27]  D. Nebert,et al.  Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. , 1985, Science.

[28]  R. Tukey,et al.  Structural gene products of the Ah locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene. , 1984, Molecular pharmacology.

[29]  H. Hoensch,et al.  Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans. , 1984, Gastroenterology.

[30]  A. Conney,et al.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. , 1982, Cancer research.

[31]  H. Strobel,et al.  Control by gastrointestinal hormones of the hydroxylation of the carcinogen benzo(a)pyrene and other xenobiotics in rat colon. , 1981, Cancer research.

[32]  J. Fouts,et al.  A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. , 1980, Analytical biochemistry.

[33]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[34]  L. Wattenberg,et al.  Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. , 1970, Cancer research.

[35]  L. Wattenberg.  Carcinogen-detoxifying mechanisms in the gastrointestinal tract. , 1966, Gastroenterology.

[36]  Y. Trottier,et al.  Rat liver cytochrome P450IA2 synthesized by transfected COS-1 cells efficiently activates food-derived promutagens. , 1991, DNA and cell biology.

[37]  F. Gonzalez,et al.  Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: Role of the enzyme in the metabolic activation of aflatoxin B1 , 1990, Molecular carcinogenesis.

[38]  J. Whitlock,et al.  Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. , 1990, Annual review of pharmacology and toxicology.

[39]  J. Hendricks,et al.  Quantitative inter-relationships between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumor response. , 1989, Carcinogenesis.

[40]  M. Correia,et al.  Role of gastrin/pentagastrin in regulation of intestinal cytochrome P-450. , 1988, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[41]  J. Whitlock.  The regulation of cytochrome P-450 gene expression. , 1986, Annual review of pharmacology and toxicology.

[42]  J. Goldstein,et al.  Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible forms of cytochrome P-450 in extrahepatic versus hepatic tissues. , 1984, Molecular pharmacology.